‘Shock and kill’ strategies require highly sensitive methods to detect HIV reactivation upon stimulation with latency reversal agents (LRAs). In this study, we validated that Fiber-optic array scanning technology (FAST) can detect reactivation of latent HIV.
Resting CD4 T cells from HIV-infected individuals or from PBMCs of uninfected donors were spinoculated with pNL4-3 virus or pLENG1-IRESGFP virus +/- an integrase inhibitor. Cells were cultured with IL-7 for 7 days and stimulated with several compounds, alone or in combination, such as prostratin (300 nM), bryostatin (1 µM), JQ1 (1 µM), or resveratrol (40 µM). After 24 hours, HIV gag or GFP expression was assessed by flow and FAST. Data are presented as mean fold increase of 3 separate experiments compared to the unstimulated control.
We validated FAST ability to detect LRA reversal by comparing it to flow using an in vitro model with a high frequency of infected cells. Stimulation with LRAs was associated with an increase in the number of GFP+ or gag+ cells (GPCs). Bryostatin was the most potent compound, inducing a consistent increase in the number of GPCs detected by FAST and flow (3.5- and 4-fold, respectively). Lower fold changes were detected by FAST and flow respectively when using prostratin (1.3-3.3 fold), JQ1 (4.1-1.9 fold), or resveratrol (1.8-3.3 fold). The association of bryostatin and JQ1 was synergistic in increasing the number of GPCs by FAST (5.7-fold increase) and flow (3.8-fold increase). Side by side comparisons of diluted in vitro infected cells as well as patient samples show FAST is more sensitive than flow. All patients had detectable levels of gag+ cells at baseline and after stimulation by FAST, but not by flow. Specifically, flow failed to robustly detect cells that express HIV proteins when the frequency of infected cells is below 1 in 10,000 due to inherent technical limitations.
FAST detects HIV proteins expressed in resting CD4+ T cells at baseline and after stimulation providing a tool to assess HIV reactivation upon stimulation with LRAs. We find a correlation between FAST and flow at high inoculum, but flow loses sensitivity at low infection frequencies. FAST has benefits over flow cytometry, including the ability to capture events that can be missed by flow, such as syncytia of cells expressing HIV proteins. In conclusion, FAST represents a novel sensitive assay, which can help characterize the baseline and inducible reservoir of HIV-infected patients.